###begin article-title 0
###xml 6 7 6 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 73 74 69 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn1">*</xref>
###xml 74 76 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn2">S&#8414;</xref>
The DEXD/H-box RNA Helicase DDX19 Is Regulated by an alpha-Helical Switch*Sâƒž
###end article-title 0
###begin p 1
Present address: Dept. of Biochemistry and Pharmacy, Abo Akademi, FI-20520 Abo, Finland.
###end p 1
###begin p 2
###xml 193 213 193 213 <email xmlns:xlink="http://www.w3.org/1999/xlink">herwig.schuler@ki.se</email>
 To whom correspondence should be addressed: Structural Genomics Consortium, Karolinska Institutet, Scheeles vag 2, S-17177 Stockholm, Sweden. Tel: 46-8-542-86843; Fax: 46-8-542-86843; E-mail: herwig.schuler@ki.se.
###end p 2
###begin p 3
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Author's Choice</italic>
Author's Choice
###end p 3
###begin p 4
 applies to Author Choice Articles
###end p 4
###begin p 5
###xml 2 3 2 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 160 161 160 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 636 637 632 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 152 157 <span type="species:ncbi:9606">human</span>
DEXD/H-box RNA helicases couple ATP hydrolysis to RNA remodeling by an unknown mechanism. We used x-ray crystallography and biochemical analysis of the human DEXD/H-box protein DDX19 to investigate its regulatory mechanism. The crystal structures of DDX19, in its RNA-bound prehydrolysis and free posthydrolysis state, reveal an alpha-helix that inserts between the conserved domains of the free protein to negatively regulate ATPase activity. This finding was corroborated by biochemical data that confirm an autoregulatory function of the N-terminal region of the protein. This is the first study describing crystal structures of a DEXD/H-box protein in its open and closed cleft conformations.
###end p 5
###begin p 6
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Author's Choice</italic>
Author's Choice-Final version full access.
###end p 6
###begin p 7
###xml 43 82 43 82 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Canadian Institutes for Health Research</grant-sponsor>
###xml 88 122 88 122 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Canadian Foundation for Innovation</grant-sponsor>
###xml 150 193 150 193 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Ontario Genomics Institute, GlaxoSmithKline</grant-sponsor>
###xml 199 220 199 220 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Karolinska Institutet</grant-sponsor>
###xml 226 262 226 262 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Knut and Alice Wallenberg Foundation</grant-sponsor>
###xml 268 292 268 292 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Ontario Innovation Trust</grant-sponsor>
###xml 298 342 298 342 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Ontario Ministry for Research and Innovation</grant-sponsor>
###xml 344 361 344 361 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Merck &amp; Co., Inc.</grant-sponsor>
###xml 367 395 367 395 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Novartis Research Foundation</grant-sponsor>
###xml 401 438 401 438 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Swedish Agency for Innovation Systems</grant-sponsor>
###xml 444 485 444 485 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Swedish Foundation for Strategic Research</grant-sponsor>
###xml 495 509 495 509 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Wellcome Trust</grant-sponsor>
This work was supported by grants from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, the Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust.
###end p 7
###begin p 8
The on-line version of this article (available at ) contains supplemental Table S1 and supplemental Figs. S1-S3.
###end p 8
###begin p 9
###xml 0 206 0 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">The atomic coordinates and structure factors (codes 3EWS and 3G0H) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (<ext-link ext-link-type="uri" xlink:href="http://www.rcsb.org/">http://www.rcsb.org/</ext-link>).</italic>
The atomic coordinates and structure factors (codes 3EWS and 3G0H) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ ().
###end p 9
###begin p 10
###xml 256 257 256 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 403 404 403 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref1">1</xref>
###xml 426 427 426 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn4">3</xref>
###xml 439 440 439 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref2">2</xref>
###xml 442 443 442 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 562 563 562 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 714 715 707 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref4">4</xref>
###xml 717 718 710 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref5">5</xref>
RNA helicase activity is involved in all aspects of RNA metabolism, including transcription, pre-mRNA splicing, ribosome biogenesis, nuclear export, translation initiation and termination, RNA degradation, viral replication, and viral RNA detection. The DEXD/H-box RNA helicases couple hydrolysis of ATP to cycles of RNA binding and release that typically result in non-processive RNA duplex unwinding (1) or disruption of RNP3 complexes (2, 3). These proteins interact in a non-sequence-specific manner with the phosphoribose backbone of single-stranded RNA. DEXD/H-box RNA helicases contain two alpha/beta-RecA-like domains that both feature conserved sequence motifs involved in RNA binding and ATP hydrolysis (4, 5). Accessory proteins are involved in the regulation of RNA binding and ATPase activities, although no general mechanism has been demonstrated.
###end p 10
###begin p 11
###xml 26 27 26 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 194 195 194 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 197 198 197 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref6">6</xref>
###xml 238 239 238 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref7">7</xref>
###xml 241 242 241 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 350 351 350 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
###xml 404 406 404 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref10">10</xref>
###xml 567 568 567 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 571 578 571 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vivo</italic>
###xml 652 654 652 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 656 658 656 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 211 216 <span type="species:ncbi:4932">yeast</span>
The DDX19 member of the DEXD/H-box RNA helicase family performs an essential function in mRNA nuclear export by remodeling RNP particles during passage of mRNA through the nuclear pore complex (3, 6). Dbp5, the yeast orthologue of DDX19 (7, 8), causes displacement of the RNP constituent, Mex67, thereby preventing re-entry of mRNA into the nucleus (9). Dbp5 is also involved in translation termination (10). A specific function has been assigned to the ADP-bound form of Dbp5, which displaces the RNA-binding protein Nab2, an event that is required for mRNA export (3). In vivo, Dbp5 is activated by the nuclear pore complex-associated protein, Gle1 (11, 12).
###end p 11
###begin p 12
###xml 24 25 24 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 228 230 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref13">13</xref>
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref17">17</xref>
###xml 238 239 238 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 514 516 514 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref18">18</xref>
###xml 617 622 <span type="species:ncbi:9606">human</span>
Crystal structures of DEXD/H-box proteins show two-lobed proteins with the nucleotide binding site located in the lower part of the cleft separating the conserved domains and the RNA binding site across the upper cleft opening (13-17). DEXD/H-box helicases in general share little homology in their coding sequences upstream of the conserved domain-1. The N-terminal extension of DDX19, however, shares significant homology with that of DDX25/GRTH, a testis-specific protein that is essential for spermatogenesis (18), supporting a functional significance for this sequence. Herein, we present a crystal structure of human DDX19 that shows the ADP-bound protein with an alpha-helical segment of the N-terminal extension wedged between the core domains, preventing cleft closure. In the structure of the ADPNP-bound protein in complex with RNA, this alpha-helix has moved out of the way to allow formation of a functional ATPase site. Our biochemical evidence supports a model for DDX19 autoregulation where the N-terminal extension helix prevents ATP hydrolysis, unless the N terminus of the protein is displaced by RNA binding, allowing cleft closure to bring key side chains into position for catalysis.
###end p 12
###begin title 13
EXPERIMENTAL PROCEDURES
###end title 13
###begin p 14
###xml 172 177 172 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink">1&#8211;479</sup>
###xml 206 212 206 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink">54&#8211;475</sup>
###xml 223 229 223 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink">92&#8211;475</sup>
###xml 442 458 442 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 482 487 482 487 <sup xmlns:xlink="http://www.w3.org/1999/xlink">1&#8211;479</sup>
###xml 518 524 518 524 <sup xmlns:xlink="http://www.w3.org/1999/xlink">54&#8211;475</sup>
###xml 555 561 555 561 <sup xmlns:xlink="http://www.w3.org/1999/xlink">92&#8211;475</sup>
###xml 679 680 678 679 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 703 704 699 700 <sc xmlns:xlink="http://www.w3.org/1999/xlink">d</sc>
###xml 798 799 788 789 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 820 821 810 811 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 832 833 822 823 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 864 865 854 855 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 352 370 <span type="species:ncbi:12227">tobacco etch virus</span>
###xml 442 470 <span type="species:ncbi:511693">Escherichia coli strain BL21</span>
Human DDX19 cDNA was obtained from the Mammalian Gene Collection (MGC; accession number BC003626) provided by the National Institute of Health. The sequences encoding DDX191-479 (full-length protein), DDX1954-475, and DDX1992-475 were amplified by PCR and inserted into pNIC28-Bsa4 by ligation-independent cloning. The expression constructs included a tobacco etch virus protease-cleavable N-terminal hexahistidine tag. Protein expression in Escherichia coli strain BL21(DE3) (DDX191-479), BL21(DE3) gold pRARE2 (DDX1954-475), or BL21(DE3) R3 pRARE (DDX1992-475) was done in Terrific Broth medium supplemented with 8 g/liter glycerol and 50 mug/ml kanamycin, induction with 0.5 mm isopropyl-1-thio-beta-d-galactopyranoside, and culture at 18 degreesC for 20 h. Cell pellets were resuspended in 50 mm HEPES, pH 7.8, 500 mm NaCl, 10 mm imidazole, 10% glycerol, 0.5 mm TCEP, and Complete EDTA-free protease inhibitor (Roche Applied Science). Cells were lysed by a freeze/thaw cycle followed by the addition of benzonase (Novagen) and sonication (Sonics VibraCell).
###end p 14
###begin p 15
###xml 126 127 126 127 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 148 149 148 149 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 160 161 160 161 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 196 197 196 197 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 258 259 258 259 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 326 327 326 327 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 441 442 441 442 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 463 464 463 464 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 494 495 494 495 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 600 601 600 601 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 696 714 <span type="species:ncbi:12227">tobacco etch virus</span>
Cleared and filtered lysates were loaded onto HiTrap chelating HP columns (GE Healthcare) pre-equilibrated with buffer 1 (30 mm HEPES, pH 7.5, 500 mm NaCl, 10 mm imidazole, 10% glycerol, and 0.5 mm TCEP). The columns were washed with buffer 1 containing 25 mm imidazole. Bound protein was eluted with buffer 1 containing 500 mm imidazole and loaded onto a HiLoad 16/60 Superdex-200 column (GE Healthcare) pre-equilibrated with buffer 2 (30 mm HEPES, pH 7.5, 500 mm NaCl, 10% glycerol, and 0.5 mm TCEP). Fractions containing DDX19 protein were pooled, and the concentration of TCEP was adjusted to 2 mm. The N-terminal hexahistidine tag was removed by incubation of DDX19 proteins with His-tagged tobacco etch virus protease at a molar ratio of 30:1 overnight at room temperature and subsequent passage over a 1-ml HisTrap HP column in buffer 1. The ADP-bound DDX19 apoenzyme structure (PDB entry 3EWS) was obtained with uncleaved protein. The purified proteins were concentrated into buffer 2 using Vivaspin (Sartorius) centrifugal concentrators. Aliquots were flash-frozen and stored at -80 degreesC. All proteins were verified by time-of-flight mass spectrometry analysis.
###end p 15
###begin p 16
###xml 23 29 23 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink">54&#8211;475</sup>
###xml 197 198 190 191 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 208 209 201 202 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 214 215 207 208 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 297 298 289 290 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 321 322 313 314 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 779 781 771 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 820 822 812 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref20">20</xref>
###xml 964 966 956 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref21">21</xref>
###xml 1037 1039 1029 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref22">22</xref>
###xml 1148 1150 1140 1142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref23">23</xref>
For the ADP-bound DDX1954-475 enzyme (PDB entry 3EWS), needle-like crystals of DDX19 were grown using vapor diffusion at 4 degreesC by mixing 0.1 mul of protein solution (18.3 mg/ml) including 20 mm ADP, 10 mm MgCl2, and 0.1 mul of reservoir solution containing 17% polyethylene glycol 10000, 0.1 m ammonium acetate, 0.1 m Bis-Tris, pH 5.5. Crystals appeared after 8 days and continued to grow for one more week. Reservoir solution supplemented with 20% glycerol was used as cryo-solution and added directly to the drop. Crystals were mounted and flash-frozen in liquid nitrogen. Diffraction data to 2.7 A resolution were collected at Berliner Elektronenspeicherring-Gesellschaft fur Synchrotronstrahlung (BESSY), Berlin, Germany (beamline BL14-2). Data were processed with XDS (19). The structure was solved by Phaser (20) using PDB entry 1FUU as a search model. Domains were searched for separately and were edited according to sequence alignment with CHAINSAW (21) before molecular replacement. The structure was refined with Phenix (22). TLS parameters were refined using individual domains as rigid groups. Model building was done using Coot (23). For further details, see supplemental Table S1.
###end p 16
###begin p 17
###xml 17 23 17 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink">54&#8211;475</sup>
###xml 242 243 235 236 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 341 342 333 334 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 358 359 350 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 371 372 363 364 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 999 1001 991 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref24">24</xref>
Crystals of DDX1954-475 in complex with RNA and Mg-ADPNP were obtained by vapor diffusion in sitting drops incubated at 4 degreesC by mixing 0.1 mul of protein solution (20 mg/ml) including 10-molar excess of decauracil ssRNA, ADPNP, and MgCl2 and 0.2 mul of reservoir solution containing 14% polyethylene glycol monomethyl ether 2000, 0.25 m trimethylamine n-oxide, 0.1 m Tris, pH 8. Crystals appeared after 7 days. Reservoir solution supplemented with 25% glycerol was used as cryosolution and added directly to the drop. Crystals were mounted and flash-frozen in liquid nitrogen. Diffraction data to 2.7 A resolution were collected at the European Synchrotron Radiation Facility (ESRF) Grenoble, France (beamline ID-29). Data were integrated and scaled using XDS. One monomer was located in the asymmetric unit. The structure was solved by Phaser using the previous DDX19 structure (PDB entry 3EWS) as a search model. Domains were searched for separately. The structure was refined with RefMac5 (24). TLS parameters were refined using individual domains as rigid groups. Model building was done using Coot. For further details, see supplemental Table S1.
###end p 17
###begin p 18
###xml 53 55 53 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref25">25</xref>
###xml 106 108 106 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref26">26</xref>
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref27">27</xref>
Geometry of the models was analyzed with Molprobity (25) Sequence alignments were obtained using ESPript (26). The figures were created using Pymol (27).
###end p 18
###begin p 19
###xml 57 58 56 57 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 67 68 66 67 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 87 88 86 87 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 97 98 96 97 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 103 104 102 103 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 110 111 109 110 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 121 122 120 121 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
ATPase activities of the DDX19 protein constructs (0.5 mum; in 30 mm HEPES, pH 7.5, 2 mm ATP, 5 mm MgCl2, 75 mm NaCl, 2 mm TCEP) were measured using the EnzChek phosphate assay kit (Invitrogen) at 22 degreesC. The assay was performed in either the presence or the absence of RNA (poly(U) RNA or poly(I)-poly(C) (Sigma-Aldrich)) and in the presence and absence of 250 units of benzonase (Merck). All presented data represent means +/- S.D. of five independent determinations.
###end p 19
###begin title 20
RESULTS AND DISCUSSION
###end title 20
###begin p 21
###xml 144 146 144 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink">54</sup>
###xml 150 153 150 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink">475</sup>
###xml 262 268 262 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 396 397 396 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 119 124 <span type="species:ncbi:9606">human</span>
In an effort to determine the mechanism of DDX19 action and of its regulation, we determined the crystal structures of human DDX19 (residues Glu54-Glu475, encompassing the two conserved domains) as a complex with ADP and as a ternary complex with ADPNP and RNA (Fig. 1; see supplemental Table S1 for details of data collection and refinement statistics). Both structures revealed the canonical DEXD/H-box RNA helicase N-terminal ATPase and C-terminal helicase domains in the typical arrangement, with the two domains coming together to form the nucleotide binding cleft.
###end p 21
###begin p 22
###xml 82 83 82 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 76 83 76 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 101 103 101 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 107 109 107 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink">68</sup>
###xml 420 421 416 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 426 427 422 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 412 427 408 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, <italic>B</italic> and <italic>E</italic></xref>
###xml 525 528 521 524 <sup xmlns:xlink="http://www.w3.org/1999/xlink">429</sup>
###xml 590 597 586 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A, C, E</italic>
###xml 603 604 599 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 582 604 578 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, <italic>A, C, E</italic>, and <italic>F</italic></xref>
###xml 607 608 603 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref6">6</xref>
###xml 610 612 606 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref28">28</xref>
###xml 700 701 696 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
The structure of RNA-free DDX19 bound to ADP revealed a surprising feature (Fig. 1A). The section Asp55-Ser68 of the N-terminal extension, which was partly disordered in the RNA complex, folded into an alpha-helix that occupied the central cleft between the two lobes. The helix extended from the RNA binding site at its N terminus to the nucleotide binding site, where it contacted the phosphate groups of ADP (Fig. 1, B and E). The helix is predicted to disrupt the ATP binding site as it displaces the arginine finger (Arg429) that is essential for the ATPase reaction to occur (Fig. 1, A, C, E, and F) (6, 28). A similar placement of a secondary structural element has never been observed in a DEXD/H-box protein.
###end p 22
###begin p 23
###xml 7 9 7 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 13 15 13 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink">68</sup>
###xml 117 118 113 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 111 118 107 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 264 266 256 258 <sup xmlns:xlink="http://www.w3.org/1999/xlink">69</sup>
###xml 317 319 309 311 <sup xmlns:xlink="http://www.w3.org/1999/xlink">70</sup>
###xml 409 410 401 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 415 416 407 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 401 416 393 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, <italic>B</italic> and <italic>E</italic></xref>
###xml 604 605 596 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 645 646 637 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 639 646 631 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>B</italic></xref>
The Asp55-Ser68 alpha-helix makes a significant number of side chain interactions with both conserved domains (Fig. 1B). The loop leading out of the C terminus of the alpha-helix hydrogen bonds with two hydroxyls of the nucleotide ribose (the backbone amide of Asn69 with the 3' hydroxyl and the backbone amide of Leu70 with the ring oxygen), suggesting selective binding to nucleotides at that site (Fig. 1, B and E). The significance of these interactions is supported by the conservation of the sequence of this N-terminal flanking segment, as well as the side chains it makes contacts with, in the DEXD/H-box RNA helicase, DDX25/GRTH (Fig. 1B and supplemental Fig. S1).
###end p 23
###begin p 24
###xml 57 59 57 59 <sub xmlns:xlink="http://www.w3.org/1999/xlink">10</sub>
###xml 186 190 186 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C, D</italic>
###xml 196 197 196 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 180 197 180 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>C, D</italic>, and <italic>F</italic></xref>
###xml 423 424 423 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 524 526 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 528 530 528 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref13">13</xref>
###xml 542 544 542 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref14">14</xref>
###xml 586 587 586 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
The structure of the ternary complex with a decauracil (U10) mRNA mimic and the non-hydrolyzable nucleotide, ADPNP, shows that both lobes contribute to nucleotide and RNA binding (Fig. 1C, D, and F and supplemental Fig. S2). Six bases of the RNA molecule are visible in the electron density, positioned across the top of the cleft; this mode of binding is consistent with the mechanism of RNA binding predicted for other DEXD/H-box RNA helicases, as determined by the structures of the complexes of RNA with DDX48/elF4AIII (12, 13) and Vasa (14). Also common to the mechanisms of the DEXD/H-box RNA helicase interactions with RNA is a kink that the proteins introduce in the RNA backbone between U4 and U5.
###end p 24
###begin p 25
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 1.</label>
###xml 9 34 9 34 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Structure of human DDX19.</bold>
###xml 34 35 34 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 133 136 133 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink">429</sup>
###xml 196 205 196 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sticks. B</italic>
###xml 336 343 336 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel A</italic>
###xml 395 402 395 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blue. C</italic>
###xml 488 491 488 491 <sup xmlns:xlink="http://www.w3.org/1999/xlink">429</sup>
###xml 519 528 519 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sticks. D</italic>
###xml 587 588 587 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 682 683 682 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 683 686 683 686 <sub xmlns:xlink="http://www.w3.org/1999/xlink">obs</sub>
###xml 689 690 689 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 690 694 690 694 <sub xmlns:xlink="http://www.w3.org/1999/xlink">calc</sub>
###xml 727 728 723 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 816 817 812 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 817 820 813 816 <sub xmlns:xlink="http://www.w3.org/1999/xlink">obs</sub>
###xml 823 824 819 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 824 828 820 824 <sub xmlns:xlink="http://www.w3.org/1999/xlink">calc</sub>
###xml 905 911 897 903 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yellow</italic>
###xml 938 941 930 933 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 982 987 974 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 9 1003 9 995 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="26"><bold>Structure of human DDX19.</bold><italic>A</italic>, overview of DDX19 with ADP bound and the N-terminal flanking helix in the central cleft. The Arg<sup>429</sup> side chain that acts as an arginine finger is presented as <italic>sticks. B</italic>, schematic representation of the cleft-inserted helix with the two conserved domains of the protein, shown in the same view as in <italic>panel A</italic>. Residues that are conserved in DDX25 are shown in <italic>blue. C</italic>, overview of the DDX19-RNA complex, with Mg-ADPNP bound in the central cleft. The Arg<sup>429</sup> side chain is presented as <italic>sticks. D</italic>, detail of the RNA binding site of the DDX19-RNA complex. <italic>E</italic>, detail of the nucleotide binding site in the open conformation, with the electron density (2<italic>F</italic><sub>obs</sub> &#8211; <italic>F</italic><sub>calc</sub>) for ADP rendered at 1.5 &#963;. <italic>F</italic>, detail of the nucleotide binding site in the RNA complex, with the electron density (2<italic>F</italic><sub>obs</sub> &#8211; <italic>F</italic><sub>calc</sub>) for Mg-ADPNP rendered at 1.5 &#963;. In all panels, the conserved domain-1 (<italic>yellow</italic>), the conserved domain-2 (<italic>red</italic>), and the N-terminal flanking sequence (<italic>green</italic>) are indicated.</p>
###xml 9 1003 9 995 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="26"><bold>Structure of human DDX19.</bold><italic>A</italic>, overview of DDX19 with ADP bound and the N-terminal flanking helix in the central cleft. The Arg<sup>429</sup> side chain that acts as an arginine finger is presented as <italic>sticks. B</italic>, schematic representation of the cleft-inserted helix with the two conserved domains of the protein, shown in the same view as in <italic>panel A</italic>. Residues that are conserved in DDX25 are shown in <italic>blue. C</italic>, overview of the DDX19-RNA complex, with Mg-ADPNP bound in the central cleft. The Arg<sup>429</sup> side chain is presented as <italic>sticks. D</italic>, detail of the RNA binding site of the DDX19-RNA complex. <italic>E</italic>, detail of the nucleotide binding site in the open conformation, with the electron density (2<italic>F</italic><sub>obs</sub> &#8211; <italic>F</italic><sub>calc</sub>) for ADP rendered at 1.5 &#963;. <italic>F</italic>, detail of the nucleotide binding site in the RNA complex, with the electron density (2<italic>F</italic><sub>obs</sub> &#8211; <italic>F</italic><sub>calc</sub>) for Mg-ADPNP rendered at 1.5 &#963;. In all panels, the conserved domain-1 (<italic>yellow</italic>), the conserved domain-2 (<italic>red</italic>), and the N-terminal flanking sequence (<italic>green</italic>) are indicated.</p></caption>
###xml 1003 1003 995 995 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0190973970001"/>
###xml 0 1003 0 995 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig1"><label>FIGURE 1.</label><caption><p textid="26"><bold>Structure of human DDX19.</bold><italic>A</italic>, overview of DDX19 with ADP bound and the N-terminal flanking helix in the central cleft. The Arg<sup>429</sup> side chain that acts as an arginine finger is presented as <italic>sticks. B</italic>, schematic representation of the cleft-inserted helix with the two conserved domains of the protein, shown in the same view as in <italic>panel A</italic>. Residues that are conserved in DDX25 are shown in <italic>blue. C</italic>, overview of the DDX19-RNA complex, with Mg-ADPNP bound in the central cleft. The Arg<sup>429</sup> side chain is presented as <italic>sticks. D</italic>, detail of the RNA binding site of the DDX19-RNA complex. <italic>E</italic>, detail of the nucleotide binding site in the open conformation, with the electron density (2<italic>F</italic><sub>obs</sub> &#8211; <italic>F</italic><sub>calc</sub>) for ADP rendered at 1.5 &#963;. <italic>F</italic>, detail of the nucleotide binding site in the RNA complex, with the electron density (2<italic>F</italic><sub>obs</sub> &#8211; <italic>F</italic><sub>calc</sub>) for Mg-ADPNP rendered at 1.5 &#963;. In all panels, the conserved domain-1 (<italic>yellow</italic>), the conserved domain-2 (<italic>red</italic>), and the N-terminal flanking sequence (<italic>green</italic>) are indicated.</p></caption><graphic xlink:href="zbc0190973970001"/></fig>
###xml 22 27 <span type="species:ncbi:9606">human</span>
FIGURE 1.Structure of human DDX19.A, overview of DDX19 with ADP bound and the N-terminal flanking helix in the central cleft. The Arg429 side chain that acts as an arginine finger is presented as sticks. B, schematic representation of the cleft-inserted helix with the two conserved domains of the protein, shown in the same view as in panel A. Residues that are conserved in DDX25 are shown in blue. C, overview of the DDX19-RNA complex, with Mg-ADPNP bound in the central cleft. The Arg429 side chain is presented as sticks. D, detail of the RNA binding site of the DDX19-RNA complex. E, detail of the nucleotide binding site in the open conformation, with the electron density (2Fobs - Fcalc) for ADP rendered at 1.5 sigma. F, detail of the nucleotide binding site in the RNA complex, with the electron density (2Fobs - Fcalc) for Mg-ADPNP rendered at 1.5 sigma. In all panels, the conserved domain-1 (yellow), the conserved domain-2 (red), and the N-terminal flanking sequence (green) are indicated.
###end p 25
###begin p 26
###xml 0 25 0 25 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Structure of human DDX19.</bold>
###xml 25 26 25 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 124 127 124 127 <sup xmlns:xlink="http://www.w3.org/1999/xlink">429</sup>
###xml 187 196 187 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sticks. B</italic>
###xml 327 334 327 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel A</italic>
###xml 386 393 386 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blue. C</italic>
###xml 479 482 479 482 <sup xmlns:xlink="http://www.w3.org/1999/xlink">429</sup>
###xml 510 519 510 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sticks. D</italic>
###xml 578 579 578 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 673 674 673 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 674 677 674 677 <sub xmlns:xlink="http://www.w3.org/1999/xlink">obs</sub>
###xml 680 681 680 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 681 685 681 685 <sub xmlns:xlink="http://www.w3.org/1999/xlink">calc</sub>
###xml 718 719 714 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 807 808 803 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 808 811 804 807 <sub xmlns:xlink="http://www.w3.org/1999/xlink">obs</sub>
###xml 814 815 810 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 815 819 811 815 <sub xmlns:xlink="http://www.w3.org/1999/xlink">calc</sub>
###xml 896 902 888 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yellow</italic>
###xml 929 932 921 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 973 978 965 970 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 13 18 <span type="species:ncbi:9606">human</span>
Structure of human DDX19.A, overview of DDX19 with ADP bound and the N-terminal flanking helix in the central cleft. The Arg429 side chain that acts as an arginine finger is presented as sticks. B, schematic representation of the cleft-inserted helix with the two conserved domains of the protein, shown in the same view as in panel A. Residues that are conserved in DDX25 are shown in blue. C, overview of the DDX19-RNA complex, with Mg-ADPNP bound in the central cleft. The Arg429 side chain is presented as sticks. D, detail of the RNA binding site of the DDX19-RNA complex. E, detail of the nucleotide binding site in the open conformation, with the electron density (2Fobs - Fcalc) for ADP rendered at 1.5 sigma. F, detail of the nucleotide binding site in the RNA complex, with the electron density (2Fobs - Fcalc) for Mg-ADPNP rendered at 1.5 sigma. In all panels, the conserved domain-1 (yellow), the conserved domain-2 (red), and the N-terminal flanking sequence (green) are indicated.
###end p 26
###begin p 27
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 2.</label>
###xml 9 93 9 93 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Role of the N-terminal flanking sequence in the regulation of DDX19 ATPase activity.</bold>
###xml 93 94 93 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 187 193 187 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N-term</italic>
###xml 221 222 221 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 9 328 9 328 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="28"><bold>Role of the N-terminal flanking sequence in the regulation of DDX19 ATPase activity.</bold><italic>A</italic>, schematic diagram of the DDX19 protein constructs used in this study (not drawn to scale). <italic>N-term</italic> represents the N terminus. <italic>B</italic>, relative ATPase activities of DDX19 protein constructs in the presence of between 0 and 0.5 mg/ml ssRNA.</p>
###xml 9 328 9 328 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="28"><bold>Role of the N-terminal flanking sequence in the regulation of DDX19 ATPase activity.</bold><italic>A</italic>, schematic diagram of the DDX19 protein constructs used in this study (not drawn to scale). <italic>N-term</italic> represents the N terminus. <italic>B</italic>, relative ATPase activities of DDX19 protein constructs in the presence of between 0 and 0.5 mg/ml ssRNA.</p></caption>
###xml 328 328 328 328 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0190973970002"/>
###xml 0 328 0 328 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig2"><label>FIGURE 2.</label><caption><p textid="28"><bold>Role of the N-terminal flanking sequence in the regulation of DDX19 ATPase activity.</bold><italic>A</italic>, schematic diagram of the DDX19 protein constructs used in this study (not drawn to scale). <italic>N-term</italic> represents the N terminus. <italic>B</italic>, relative ATPase activities of DDX19 protein constructs in the presence of between 0 and 0.5 mg/ml ssRNA.</p></caption><graphic xlink:href="zbc0190973970002"/></fig>
FIGURE 2.Role of the N-terminal flanking sequence in the regulation of DDX19 ATPase activity.A, schematic diagram of the DDX19 protein constructs used in this study (not drawn to scale). N-term represents the N terminus. B, relative ATPase activities of DDX19 protein constructs in the presence of between 0 and 0.5 mg/ml ssRNA.
###end p 27
###begin p 28
###xml 0 84 0 84 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Role of the N-terminal flanking sequence in the regulation of DDX19 ATPase activity.</bold>
###xml 84 85 84 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 178 184 178 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N-term</italic>
###xml 212 213 212 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
Role of the N-terminal flanking sequence in the regulation of DDX19 ATPase activity.A, schematic diagram of the DDX19 protein constructs used in this study (not drawn to scale). N-term represents the N terminus. B, relative ATPase activities of DDX19 protein constructs in the presence of between 0 and 0.5 mg/ml ssRNA.
###end p 28
###begin p 29
###xml 300 301 288 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 294 301 282 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>D</italic></xref>
###xml 434 437 416 419 <sup xmlns:xlink="http://www.w3.org/1999/xlink">227</sup>
###xml 477 480 459 462 <sup xmlns:xlink="http://www.w3.org/1999/xlink">202</sup>
###xml 488 491 470 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink">223</sup>
DDX19 differs from DDX48 and Vasa in the binding to RNA downstream of the kink. In the DDX48 and Vasa structures, U5 and U6 remain stacked with each other on the 3' side of the kink, whereas in DDX19, the U6 base is rotated through approximately150 degrees around the sugar-phosphate backbone (Fig. 1D). This conformation is stabilized by hydrogen-bonding interactions between the 2'-ribose hydroxyl of U6 and the epsilon-amide of Lys227 and between the uracil base and the Lys202 and Asp223 side chains. Structure overlays suggest that a similar flipped conformation of U6 could not be accommodated by either DDX48 or Vasa.
###end p 29
###begin p 30
###xml 283 284 283 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 289 290 289 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 275 290 275 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, <italic>B</italic> and <italic>E</italic></xref>
###xml 411 412 411 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 405 412 405 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>A</italic></xref>
###xml 462 463 462 463 <sup xmlns:xlink="http://www.w3.org/1999/xlink">1</sup>
###xml 467 470 467 470 <sup xmlns:xlink="http://www.w3.org/1999/xlink">479</sup>
###xml 595 597 581 583 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;1</sup>
###xml 631 632 617 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 625 632 611 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 668 670 654 656 <sup xmlns:xlink="http://www.w3.org/1999/xlink">54</sup>
###xml 674 677 660 663 <sup xmlns:xlink="http://www.w3.org/1999/xlink">475</sup>
###xml 928 930 902 904 <sup xmlns:xlink="http://www.w3.org/1999/xlink">92</sup>
###xml 934 937 908 911 <sup xmlns:xlink="http://www.w3.org/1999/xlink">475</sup>
The interactions of the cleft-inserted helix with the conserved domains and with the nucleotide attest to the specificity and selectivity of the positioning of the N-terminal extension and point to a potential regulatory mechanism for the intrinsic ATPase activity of DDX19 (Fig. 1, B and E). To investigate this possibility, we measured the ATPase activities of three different DDX19 protein constructs (Fig. 2A). In the absence of ssRNA, full-length DDX19 (Met1-Asn479) did not hydrolyze appreciable amounts of ATP, but ATPase activity was stimulated to a rate of approximately0.77 +/- 0.2 min-1 (S.D.) by 0.5 mg/ml ssRNA (Fig. 2B). The shorter protein construct Glu54-Glu475, lacking the native N terminus but containing the cleft insertion helix, hydrolyzed ATP at an intermediate rate of approximately25% of the ssRNA-stimulated full-length protein. This activity was independent of the presence of ssRNA. The construct Lys92-Glu475, which also lacked the cleft insertion alpha-helix, displayed the highest turnover of ATP (approximately200% of the ssRNA-stimulated full-length protein), again independent of the presence of ssRNA. Further tests showed that the ATPase activities of the DDX19 proteins were not stimulated nor inhibited by the presence of double-stranded RNA (supplemental Fig. S3).
###end p 30
###begin p 31
###xml 89 91 89 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink">92</sup>
###xml 95 98 95 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink">475</sup>
###xml 195 197 195 197 <sup xmlns:xlink="http://www.w3.org/1999/xlink">54</sup>
###xml 201 204 201 204 <sup xmlns:xlink="http://www.w3.org/1999/xlink">475</sup>
###xml 341 345 341 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i.e.</italic>
Taken together, these results show that the core DEAD and helicase domains (construct Lys92-Glu475) form an active, RNA-independent ATPase. The addition of the cleft-inserted helix (construct Glu54-Glu475) represses the ATPase activity of the core protein but does not confer RNA dependence to it. Further addition of the native N terminus (i.e. resulting in full-length DDX19) completely abolishes the ATPase activity of the protein in the absence of ssRNA. The presence of ssRNA overcomes the complete inhibition of ATPase activity in the full-length protein. The presence of the native N terminus is also required for ssRNA concentration-dependent stimulation of ATPase activity, indicating that ssRNA binding is sufficient to displace the N terminus, release the helix from the cleft, and allow formation of the catalytic triad in the ATP binding site.
###end p 31
###begin p 32
###xml 72 74 72 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref29">29</xref>
###xml 747 748 743 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 107 112 <span type="species:ncbi:9606">human</span>
RNA- and ATP-induced cleft closure has been shown to occur in solution (29), and the crystal structures of human DDX19 presented here demonstrate how cleft closure can be utilized in the regulation of ATPase activity. Our results suggest a model where an alpha-helical segment of the N-terminal flanking region is inserted between the core domains in the RNA-free protein. This helix prevents cleft closure and positions the N-terminal flanking sequence in the RNA binding groove or in its proximity. RNA binding then displaces the native N terminus, releasing the helix from the cleft to allow formation of the closed state and subsequent nucleotide hydrolysis. We predict that this mechanism of autoregulation also applies to DDX25, the other DEXD/H-helicase in which the sequence of the cleft insertion helix is highly conserved, and possibly to other family members.
###end p 32
###begin title 33
Supplementary Material
###end title 33
###begin title 34
[Supplemental Data]
###end title 34
###begin p 35
We gratefully acknowledge the staffs of the BESSY (Berlin, Germany) and ESRF (Grenoble, France) synchrotron radiation facilities. We thank Lovisa Holmberg-Schiavone for initiating this project and Aled Edwards for critical reading of the manuscript.
###end p 35
###begin p 36
The abbreviations used are: RNP, ribonucleoprotein; ADPNP, adenosine 5'-(beta, gamma-imido)triphosphate; ssRNA, single-stranded RNA; PDB, Protein Data Bank; TCEP, tris(2-carboxyethyl)phosphine; Bis-Tris, 2-(bis(2-hydroxyethyl)amino)-2-(hydroxymethyl)propane-1,3-diol.
###end p 36

